Arguments for a different regulatory categorization and framework for stromal vascular fraction

Ricardo L. Rodriguez, Trivia Frazier, Bruce A. Bunnell, Cecilia A. Mouton, Keith L. March, Adam J. Katz, J. Peter Rubin, Ramon Llull, Jens A. Sørensen, Jeffrey M. Gimble*

*Kontaktforfatter for dette arbejde

Publikation: Bidrag til tidsskriftTidsskriftartikel

Abstrakt

Although adipose tissue and cells show considerable promise for clinical translation in the emerging field of regenerative medicine, they present a challenge to the regulatory community both nationally and internationally. This commentary evaluates the status of adipose-derived therapeutics and considers regulatory approaches designed to maximize patient safety while advancing clinical translation in accordance with evidence-based medical science.

OriginalsprogEngelsk
TidsskriftStem Cells and Development
Vol/bind29
Udgave nummer5
Sider (fra-til)257-262
ISSN1547-3287
DOI
StatusUdgivet - 1. mar. 2020

Fingeraftryk Dyk ned i forskningsemnerne om 'Arguments for a different regulatory categorization and framework for stromal vascular fraction'. Sammen danner de et unikt fingeraftryk.

  • Citationsformater

    Rodriguez, R. L., Frazier, T., Bunnell, B. A., Mouton, C. A., March, K. L., Katz, A. J., Rubin, J. P., Llull, R., Sørensen, J. A., & Gimble, J. M. (2020). Arguments for a different regulatory categorization and framework for stromal vascular fraction. Stem Cells and Development, 29(5), 257-262. https://doi.org/10.1089/scd.2019.0096